← Leaderboards
Seiji Kondo
Cleveland Clinic Foundation
$2,413,036
Attributed
$2,413,036
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $309.6K · FY2005–06$500K$375K$250K$125K$0
'05
'06
Funding mix
By agency
NIH$2,413,036 · 3
By mechanism
R01$2,413,036 · 3
Top collaborators
No co-investigators on record.
Most similar at Cleveland Clinic Foundation
Same institution · by research overlap
- Alexandru Almasan Almasan$5,940,007
- James H Finke$9,274,196
- George Thomas Budd$2,197,828
- Kurt W Runge$10,236,593
- Alan Wolfman$1,163,650
Others in their field
Top investigators on “Athymic Mouse”
- Thomas F Deuel · Beth Israel Deaconess Medical Center$7,283,721
- Ralph Weissleder · Massachusetts General Hospital$5,688,124
- Donald P McDonnell · Duke University$5,386,390
- Oliver W. Press · Fred Hutchinson Cancer Research Center$5,178,285
- Channing J Der · University Of North Carolina Chapel Hill$4,926,790
- Murray Korc · University Of California Irvine$4,764,672
Research focus
Athymic MouseNeoplasm /Cancer ChemotherapyGliomaTelomeraseApoptosisNonhuman Therapy EvaluationCombination Cancer TherapyNeoplasm /Cancer Radiation TherapyEnzyme ActivityCombination ChemotherapyCisplatinCysteine EndopeptidasesGenetic Promoter ElementBcl2 Gene /ProteinGamma RadiationNeoplasm /Cancer TherapyTransfection /Expression VectorFluorescence MicroscopyGreen Fluorescent ProteinsImmunocytochemistryLuciferin MonooxygenaseGene TherapyTemozolomideNeoplastic Cell
Grant awards (11)
Treatment of Malignant Gliomas with 2-5A-anti-hTR$302,276
R01 · FY2006 · CA · contact PI
Treatment of Malignant Gliomas with 2-5A-anti-hTR$309,550
R01 · FY2005 · CA
Treatment of Malignant Gliomas with 2-5A-anti-hTR$309,550
R01 · FY2004 · CA
Telomerase Specific Caspase Transfer for Gliomas$237,825
R01 · FY2004 · CA
Telomerase Specific Caspase Transfer for Gliomas$237,825
R01 · FY2003 · CA
Telomerase Specific Caspase Transfer for Gliomas$194,073
R01 · FY2002 · CA
Telomerase Specific Caspase Transfer for Gliomas$72,890
R01 · FY2002 · CA
Telomerase Specific Caspase Transfer for Gliomas$266,963
R01 · FY2001 · CA
TREATMENT OF BRAIN TUMORS WITH 2-5A-ANTITELOMERASE RNA$247,541
R01 · FY2001 · CA
TREATMENT OF BRAIN TUMORS WITH 2-5A-ANTITELOMERASE RNA$200,278
R01 · FY2000 · CA
TREATMENT OF BRAIN TUMORS WITH 2-5A-ANTITELOMERASE RNA$34,265
R01 · FY2000 · CA